SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July ~~June 9~~7, 2005

~~Able~~ABLE ~~Laboratories~~LABORATORIES, ~~Inc~~INC.

(Exact Name of Registrant as Specified in Charter)

Delaware	001-11352	04-3029787
(State or other jurisdiction	(Commission	(IRS Employer
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification Number)
of incorporation)	File Number)	Identification Number)

1 Able Drive, Cranbury, NJ 08512 ~~(Address of principal executive offices) (Zip Code)~~

(~~609)~~Address ~~495-2800~~of ~~(Registrant’s~~principal ~~telephone~~executive ~~number,~~offices) ~~including~~(Zip ~~area code~~Code)

(609) 495-2800

(Registrant’s telephone number, including area code)

Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below).

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

~~Item~~o Pre-commencement ~~8.01~~communications ~~Other~~pursuant ~~Information~~to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Ono Pre-commencement ~~June~~communications 9,pursuant ~~2005,~~to ~~the~~Rule ~~Company~~13e-4(c) ~~issued~~under athe ~~press~~Exchange ~~release~~Act ~~regarding~~(17 ~~its~~CFR ~~reduction in workforce~~240. ~~A copy of that press release is filed with this current report as an exhibit.~~13e-4(c))

OnItem ~~June 10, the Company issued a press release regarding its annual stockholder meeting~~5.02 ADeparture ~~copy~~ of ~~that~~Directors ~~press~~or ~~release~~Principal isOfficers; ~~filed~~Election ~~with~~of ~~this~~Directors; ~~current~~Appointment ~~report~~of asPrincipal ~~an exhibit.~~Officers

~~Item~~On 9July 7, 2005, Able Laboratories, Inc.01 ~~Financial~~announced ~~Statements~~that Robert G. Mauro, its President and ~~Exhibits~~interim Chief Executive Officer and a director, had tendered his resignation, and the Company had accepted his resignation from each of those positions. The full text of the press release is attached as Exhibit 99.1 to this Report and is incorporated by reference herein.

~~(c)~~Item ~~Exhibits~~8.01 Other Events

99.1	Press Release dated June 9, 2005
99.2	Press Release dated June 10, 2005

On July 1, 2005, the Company filed a press release relating to its annual meeting. A copy of the press release is attached as Exhibit 99.2.

~~SIGNATURES~~Item 9.01 Financial Statements and Exhibits

~~Pursuant~~(c) ~~to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.~~Exhibits

ABLE LABORATORIES, INC.

99.1	Press Release dated July 7, 2005
99.2	Press Release dated June 30, 2005

~~By: /s/ Nitin Kotak~~_________________

~~Nitin Kotak~~SIGNATURES

~~Vice~~Pursuant ~~President~~to the requirements of the Securities Exchange Act of 1934, ~~Finance~~the ~~and~~Registrant ~~Accounting~~has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

~~Date:~~ABLE ~~June 15~~LABORATORIES, ~~2005~~INC.

By: /s/ Nitin Kotak

Nitin Kotak
Vice President, Finance and Accounting

Date: July 8, 2005

Exhibit Index

Exhibit No.	Description
99.1	Press Release dated July 7, 2005
99.2	Press Release dated June 30, 2005
_________________

Filing Compare · ABLE LABORATORIES INC